Valeo Financial Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Valeo Financial Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 12, 2021	SELL	$72.25 - $168.95 $6,069 - $14,191	-84 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$125.56 - $178.74 $12,556 - $17,874	-100 Reduced 54.35%	84 $14,000
Q3 2020 Oct 28, 2020	SELL	$127.12 - $172.34 $11,949 - $16,199	-94 Reduced 33.81%	184 $26,000
Q2 2020 Jul 20, 2020	BUY	$93.0 - $171.7 $186 - $343	2 Added 0.72%	278 $45,000
Q1 2020 Apr 13, 2020	SELL	$82.38 - $131.64 $247 - $394	-3 Reduced 1.08%	276 $29,000
Q2 2019 Jul 10, 2019	SELL	$112.21 - $151.95 $336 - $455	-3 Reduced 1.06%	279 $42,000
Q1 2019 Apr 12, 2019	BUY	$106.67 - $151.68 $8,000 - $11,376	75 Added 36.23%	282 $34,000
Q4 2018 Jan 30, 2019	BUY	$97.32 - $148.76 $583 - $892	6 Added 2.99%	207 $23,000
Q3 2018 Nov 01, 2018	BUY	$115.31 - $161.51 $1,268 - $1,776	11 Added 5.79%	201 $25,000
Q1 2018 Apr 12, 2018	SELL	$54.02 - $82.27 $54,020 - $82,270	-1,000 Reduced 84.03%	190 $14,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $42,518 - $56,108	1,190	1,190 $54,000

535

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.49B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.